Thirteen @entity1 with advanced @entity356 treated by palliative radiotherapy were retrospectively analyzed. The radiation sites were abdominal cavities in 8 cases, superficial masses in 5 and lung metastasis in one. The purposes were to diminish mass size in 5 cases, to relieve @entity158 in 3 and to reduce @entity850 in 6. The total doses were more than 40 Gy in 10 @entity1 . In 2 cases, the intracavitary irradiation was performed using 192Ir. In one case, radiation had to be stopped at the dose of 22.5 Gy because of poor general condition. Partial response was obtained in 6 of 12 cases ( @entity6391 , 50%). The sites of responders were superficial lesions in 4 and hepatic hilar mass in 2, which were given intracavitary as well as external radiation. @entity158 relief was achieved in all @entity1 suffering from it. One of 3 cases with @entity3332 showed marked improvement in swallowing. Two @entity1 showed a decrease in the levels of @entity5 markers. Five @entity1 had side effects of more than grade 2. Two of them were grade 3, one @entity882 and one @entity294 . The median survival time of all cases was 9 months, and 5 @entity1 could shift to home care. These results suggest that palliative radiotherapy could be one of the most useful locoregional therapies for advanced @entity356 , in the aspect of improvement of @entity1 's QOL.

[Radiation therapy for advanced XXXX ].

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity3332 :: ('MESH:D004940', 'Disease') :: ['esophageal stenosis'] @entity882 :: ('MESH:D013921', 'Disease') :: ['thrombocytopenia'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor'] @entity294 :: ('MESH:D003967', 'Disease') :: ['diarrhea'] @entity6391 :: ('MESH:D012174', 'Disease') :: ['RP'] @entity158 :: ('MESH:D010146', 'Disease') :: ['Pain', 'pain'] @entity850 :: ('MESH:D003251', 'Disease') :: ['stenosis'] @entity356 :: ('MESH:D013274', 'Disease') :: ['gastric cancer']
@entity356 :: (MESH:D013274,Disease) :: ['gastric cancer']
